Overview of Dr. Lipska
I am an endocrinologist at the Yale School of Medicine and a Clinical Investigator at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation (CORE). My research program seeks to better understand the balance of benefits and harms of glucose-lowering therapy in older adults with type 2 diabetes. My current research projects are primarily focused on severe hypoglycemia. I am investigating trends in admissions for hypoglycemia among the elderly Medicare population; race, sex, and age disparities in these admissions; using qualitative research methods to explore reasons for hypoglycemia admissions; examining key risk factors for hypoglycemia; and developing prediction models for hypoglycemia. Based on these data, I seek to develop and implement decision support tools to help clinicians and patients make better decisions about their care. My overall goals are to generate data that patients and clinicians need—data which currently do not exist—so that they can make better, smarter treatment decisions.
In addition, Dr. Lipska works at CORE on the development of ambulatory care quality measures for the Centers for Medicare & Medicaid Services (CMS). She is currently leading the development of an outcome measure of care quality among people with diabetes mellitus.
Office
789 Howard Avenue 2nd Floor
Dana Building
New Haven, CT 06519
Education & Training
- Yale-New Haven HospitalPost-Doctoral Fellowship, 2009 - 2011
- Yale UniversityM.H.Sc., 2011
- Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
- Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
- Harvard Medical SchoolClass of 2003
- Yale UniversityB.S., Molecular Biochemistry and Biophysics, Cum Laude, 1997
Certifications & Licensure
- CT State Medical License 2012 - 2025
- MA State Medical License 2006 - 2007
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Young Investigator Career Development Award in Geriatric Endocrinology ADA-ASP, 2013
- Grants for Early Medical/Surgical Specialists’ Transition to Aging (GEMSSTAR) Award 2013
- Pepper Research Career Development Core Scholar Award 2013
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsAssociation of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy.Kasia J Lipska, Carol Oladele, Kelson Zawack, Barbara Gulanski, Pradeep Mutalik
Diabetes Technology & Therapeutics. 2024-12-01 - Risk of Infection in Older Adults With Type 2 Diabetes With Relaxed Glycemic Control.Kasia J Lipska, Lisa K Gilliam, Catherine Lee, Jennifer Y Liu, Vincent X Liu
Diabetes Care. 2024-12-01 - Cost-Related Prescription Drug Rationing by Adults With Obesity.Alissa S Chen, Caroline G Borden, Maureen E Canavan, Joseph S Ross, Carol R Oladele
JAMA Network Open. 2024-11-04
Journal Articles
- Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Achieving Normal Thyrotropin LevelsJuan P Brito, Robert C Smallridge, Victor Bernet, Kasia J Lipska, JAMA Network Open
- Is the Over-the-Counter Availability of Human Insulin in the United States Good or Bad?Kasia J. Lipska, Madeline McCrary, JAMA
- Availability and Affordability of Essential Medicines: Implications for Global Diabetes TreatmentKasia Lipska, Irl B. Hirsch, Current Diabetes Reports
- Join now to see all
Lectures
- Lilacs, Lactate, Lies, and Labels1/1/2016
- Type 2 Diabetes in Older Patients1/1/2016
- Join now to see all
Other
- Break up the insulin racketLipska K, The New York Times
1/20/2016 - When diabetes treatment goes too farLipska K, The New York Times
1/12/2015 - The global diabetes epidemicLipska K, The New York Times
1/25/2014 - Join now to see all
Press Mentions
- Infection Monitoring Needed for Older Adults with Elevated A1COctober 28th, 2024
- Ahead of Senate Hearing, Doctors Decry 'Exorbitant' Cost of Ozempic and WegovySeptember 16th, 2024
- Ahead of Novo Nordisk Hearing, 250 Clinicians Demand Affordable Access to Ozempic and WegovySeptember 16th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: